Previous Article | Next Article 
Journal of Bacteriology, September 1999, p. 5330-5340, Vol. 181, No. 17
0021-9193/99/$04.00+0
Identification of a Two-Component Signal Transduction System from
Corynebacterium diphtheriae That Activates Gene Expression
in Response to the Presence of Heme and Hemoglobin
Michael P.
Schmitt*
Laboratory of Bacterial Toxins, Division of
Bacterial Products, Center for Biologics Evaluation and Research,
Food and Drug Administration, Bethesda, Maryland 20892
Received 7 May 1999/Accepted 30 June 1999
 |
ABSTRACT |
Corynebacterium diphtheriae, the causative agent of
diphtheria, utilizes various host compounds to acquire iron. The
C. diphtheriae hmuO gene encodes a heme oxygenase that is
involved in the utilization of heme and hemoglobin as iron sources.
Transcription of the hmuO gene in C. diphtheriae is controlled under a dual regulatory mechanism in
which the diphtheria toxin repressor protein (DtxR) and iron repress
expression while either heme or hemoglobin is needed to activate
transcription. In this study, two clones isolated from a C. diphtheriae chromosomal library were shown to activate
transcription from the hmuO promoter in Escherichia
coli. Sequence analysis revealed that these activator clones each
carried distinct genes whose products had significant homology to
response regulators of two-component signal transduction systems.
Located upstream from each of these response regulator homologs are
partial open reading frames that are predicted to encode the C-terminal
portions of sensor kinases. The full-length sensor kinase gene for each of these systems was cloned from the C. diphtheriae
chromosome, and constructs each carrying one complete sensor kinase
gene and its cognate response regulator were constructed. One of these constructs, pTSB20, which carried the response regulator
(chrA) and its cognate sensor kinase (chrS),
was shown to strongly activate transcription from the hmuO
promoter in a heme-dependent manner in E. coli. A mutation
in chrA (chrAD50N), which changed a conserved aspartic acid residue at position 50, the presumed site of
phosphorylation by ChrS, to an asparagine, abolished heme-dependent
activation. These findings suggest that the sensor kinase ChrS is
involved in the detection of heme and the transduction of this signal, via a phosphotransfer mechanism, to the response regulator ChrA, which
then activates transcription of the hmuO promoter. This is
the first report of a bacterial two-component signal transduction system that controls gene expression through a heme-responsive mechanism.
 |
INTRODUCTION |
Corynebacterium
diphtheriae is a gram-positive, nonsporulating bacterium that is
the causative agent of diphtheria. The primary virulence determinant in
C. diphtheriae is the diphtheria toxin (DT), a 58,000-Da
secreted protein which has been extensively studied (31).
The tox gene, which encodes DT, is regulated at the
transcriptional level by the diphtheria toxin repressor protein (DtxR)
and iron (2, 38). DtxR, which is functionally similar to the
Escherichia coli ferric uptake repressor protein (Fur) (13), is a global iron-dependent repressor that regulates
the expression of at least eight genes in C. diphtheriae
(2, 23, 36, 38, 40, 41, 45). The importance of iron in the
regulation of bacterial virulence determinants has been well
established, and the ability to acquire sufficient iron during
infection has been shown to be important for a number of bacterial
pathogens to be fully virulent (10, 24, 49).
Systems involved in the acquisition of iron by bacteria include
high-affinity siderophore transport systems (3) and
siderophore-independent mechanisms in which bacterial pathogens utilize
iron from various host sources, such as transferrin, lactoferrin, heme,
or hemoglobin (22, 26). The molecular mechanism involved in
the transport of heme and its subsequent utilization as an iron source
has been examined in several gram-negative pathogens (15, 18, 22, 28, 30, 43, 44, 46, 51). These systems include a heme-specific outer membrane receptor, which is required for the uptake of heme into
the periplasm, and an ATP-binding cassette transporter complex that is
involved in the transport of heme through the cytoplasmic membrane. It
was proposed that these bacteria contain a heme oxygenase-like enzyme
that functions in the removal of the heme-bound iron (22, 44). However, proteins with a heme-degrading activity have not been identified in any of these gram-negative species, and the mechanism involved in the extraction of iron from heme remains to be determined.
In C. diphtheriae, the ability to utilize iron from
transferrin was shown to be siderophore dependent, while the use of
iron from heme and hemoglobin was independent of the siderophore uptake system (36). Mutants of C. diphtheriae and
Corynebacterium ulcerans that were unable to utilize heme
and hemoglobin as iron sources have been isolated and characterized
(36). Clones carrying the C. diphtheriae hmuO
gene were shown to complement several of the Corynebacterium
heme utilization mutants. The product of the hmuO gene has
significant amino acid homology to eukaryotic heme oxygenases. Heme
oxygenases, which had not been previously identified in bacteria but
are well known in eukaryotic systems, are involved in the oxidative
degradation of heme through the cleavage of the heme porphyrin ring and
the subsequent production of CO, iron, and biliverdin (25).
The HmuO protein from C. diphtheriae was purified and shown
to have an enzymatic activity that is similar to that observed for
eukaryotic heme oxygenases (50). It is proposed that the
role of HmuO in the utilization of heme as an iron source in C. diphtheriae is in the degradation of heme and the subsequent release of the heme-bound iron. It is believed that
Corynebacterium mutants deficient in HmuO activity are
unable to extract the iron from heme and, therefore, defective in their
ability to use heme as an iron source. Bacterial heme oxygenases have
recently been identified in species of Cyanobacterium
(5).
In gram-negative bacteria, most of the systems involved in the
transport and utilization of heme-bound iron are repressed in high-iron
environments; this repression is mediated through the Fur protein
(22, 30, 51). In pathogenic species of
Haemophilus, the expression of the transferrin and
hemoglobin receptors is repressed by heme (8, 19, 29). The
mechanism involved in this regulation has not been determined.
Expression studies with the C. diphtheriae hmuO gene
revealed that transcription from the hmuO promoter was under
a dual regulatory mechanism, which involved repression by DtxR and iron
and activation by heme (37). DNase I footprinting
experiments showed that purified DtxR, in the presence of a divalent
metal, bound to an approximately 30-bp region that overlapped the
hmuO promoter. Expression of the hmuO promoter
from a promoter-probe plasmid in C. diphtheriae revealed that only low levels of transcription were observed unless a heme source, either heme or hemoglobin, was added to the growth medium. Northern blot analysis and primer extension studies provided additional evidence that transcription of the hmuO gene was activated
by heme (37). Genes that are activated by heme or other
heme-containing compounds have not been previously reported for
bacteria; however, several genes in eukaryotic systems, including those
encoding certain heme oxygenases, are regulated at the transcriptional level by heme (52).
In this study, the mechanism involved in heme activation of the
hmuO promoter was investigated. Two independent clones from a C. diphtheriae library were shown to activate expression
of an hmuO promoter-lacZ fusion construct in
E. coli. The recombinant plasmids were shown to encode the
genes designated chrA and cstA, whose predicted
products are homologous to response regulators of two-component signal
transduction systems. Immediately upstream from chrA and
cstA are open reading frames that are predicted to encode
the cognate sensor kinase genes, which have been designated chrS and cstS, respectively. A construct carrying
the entire coding region for chrS and its cognate response
regulator chrA was shown to activate expression of the
hmuO promoter in E. coli in the presence of heme.
This is the first report of a two-component signal transduction system
in which transcriptional activation is mediated through heme.
 |
MATERIALS AND METHODS |
Bacterial strains and media.
E. coli DH5
(Bethesda
Research Laboratories, Gaithersburg, Md.) was used throughout this
study in the analysis of the hmuO promoter-lacZ
reporter fusion constructs (PhmuO-lac) and for routine plasmid isolation. C. diphtheriae C7(
) (17) was
originally obtained from the strain collection of Randall K. Holmes.
Luria-Bertani (LB) medium (27) was used for culturing of
E. coli, while heart infusion broth (Difco, Detroit, Mich.)
containing 0.2% Tween 80 (HIBTW) was used for growth of C. diphtheriae C7(
). Permanent stocks of bacterial strains were
maintained in 20% glycerol at
70°C. When needed, antibiotics were
added to LB medium for E. coli as follows: 10 µg of
tetracycline/ml, 34 µg of chloramphenicol/ml, and 100 µg of
ampicillin/ml. Chloramphenicol at 2 µg/ml was added to HIBTW for
growth of C. diphtheriae strains which harbor plasmids. LB
medium and HIBTW were made low iron by the addition of ethylenediamine di(o-hydroxyphenylacetic acid) (EDDA) which was deferrated
by the method of Rogers (33). EDDA was added to
HIBTW-containing media at 50 µg/ml and to LB media at 2.5 µg/ml.
Hemin (bovine) was added to C. diphtheriae cultures at 25 µg/ml and to E. coli cultures at 100 µg/ml, and
hemoglobin (human) was added to cultures of both types at 10 µM.
Isopropyl-
-D-thiogalactopyranoside (IPTG) (Bethesda
Research Laboratories) was used at 0.5 mM. Antibiotics, EDDA, Tween 80, hemin, and hemoglobin were purchased from Sigma Chemical Co. (St.
Louis, Mo.).
Plasmid construction and DNA manipulation.
The promoter
probe vector pCM502 (Cmr) (37), which contains a
promoterless lacZ gene, was used for the construction of the six PhmuO-lac fusion plasmids (see Fig. 1). The DNA inserts
present in the six PhmuO-lac fusion plasmids were generated
by using PCR and seven different oligonucleotide primers. Six of the
primers, designated PO-1, PO-2, PO-3, PO-4, PO-5, and PO-6, are 32 nucleotides (nt) in length: the 17-nt sequences at their 3' ends are
complementary to unique sequences upstream of the hmuO
promoter (sense strand), and the 15-nt sequences at the 5' ends contain
a SalI site. The primer on the antisense strand, designated
PO-Bam, was used in PCRs with each of the six primers
described above to generate the inserts in the various
PhmuO-lac fusions. The primer PO-Bam contains
sequences at its 3' region that are complementary to a sequence 240 bp
downstream from the hmuO promoter, and it contains a unique
BamHI site in a 5' tail region. The six PCR products each
have a unique SalI site in the region upstream of the
hmuO promoter and a unique BamHI site in the
downstream sequence. The six fragments were digested with
BamHI and SalI and then ligated into the
corresponding sites in pCM502 to generate the PhmuO-lac fusions for which maps are shown in Fig. 1. All of the fragments terminated at different locations upstream of the hmuO
promoter but shared a common downstream terminus. The DNA sequences of the inserts in the six promoter fusion plasmids were determined, and it
was confirmed that no sequence changes had occurred during construction
of these plasmids.
Plasmids pWKS30 and pWSK29, which carry ampicillin resistance
determinants, are low-copy-number plasmids that contain the pSC101
origin of replication (47) and were used in the construction of the plasmids pTSB20, pTSB50, and pTSB20-50. The plasmid pTSB20 was
constructed in a two-step process, as follows: the 1.5-kb BamHI-HindIII fragment was excised from
pTSB2.B (Fig. 2) and ligated into the
BamHI-HindIII site of pWKS30 to generate
plasmid pW2-1.5. In the second step, the 1.5-kb HindIII
fragment in pKSH51 (identified from the colony hybridization; see
below) was ligated into the HindIII site of pW2-1.5 to
create pTSB20. The plasmid pTSB50 was also generated in a two-step
process as follows: the 2.4-kb PstI-EcoRI insert
in pTSB5.R (Fig. 3) was ligated into the
PstI-EcoRI site of pWSK29 to produce plasmid
pW5-2.4. In the second step, a 1.2-kb PstI fragment in
pR5-38 (obtained from the colony hybridization; see below) was ligated
to the PstI site in pW5-2.4 to create pTSB50. Plasmid
pTSB20-50 was constructed by ligating the 3.5-kb insert of pTSB20
(present on a PvuII fragment) into a HindIII
site of pTSB50. The HindIII site, which is present in
vector sequences, was made blunt prior to ligation. All of the genes
present on pTSB20, pTSB50, and pTSB20-50 are oriented such that they
are predicted to be under transcriptional control of the lac
promoter on the vector.
The plasmid pTSB2-5 was constructed by ligating the 2-kb
BamHI fragment from pTSB2.B into the BamHI site
of pTSB5.R. The 2-kb BamHI fragments in pTSB2-5 and in
pTSB2.B are in the same orientation relative to the trc
promoter present on plasmid pTrc99A. The pSHU9 plasmid
(Tcr, pAT153 replicon) was a gift from Shelley M. Payne,
University of Texas at Austin, and it contains a 9-kb insert that
carries genes for the heme transport system from Shigella
dysenteriae (28). To optimize expression of the heme
transport genes on pSHU9, EDDA was added to the growth medium at 2.5 µg/ml. The plasmid pBluescript KS (Stratagene, La Jolla, Calif.) was
used for routine cloning experiments and for preparing DNA for
sequencing. Plasmids were transformed into C. diphtheriae by
electroporation (14) and into E. coli as
previously described (12).
Construction of the C. diphtheriae chromosomal
library.
The expression vector pTrc99A
(Ampr) (Pharmacia, Milwaukee, Wis.), which was used in the
construction of the C. diphtheriae library, contains the
pBR322 origin of replication and the lacIq gene.
The plasmid library was constructed as follows. C. diphtheriae C7(
) chromosomal DNA was isolated as previously
described (42) and then partially digested with
Sau3AI. DNA fragments of 3 to 7 kb were excised from a 1%
agarose gel and purified by using a Gene Clean Spin kit from Bio 101 (Vista, Calif.). The DNA fragments were ligated into the
BamHI site of the pTrc99A vector that had been
treated with shrimp alkaline phosphatase (Amersham, Cleveland, Ohio).
Identification and cloning of fragments from the C7(
)
chromosome that carry the sensor kinase genes.
Since plasmids
pTSB2 and pTSB5 carry only the 3' portions of the coding regions for
the cstS and chrS genes, additional restriction mapping analysis of the C. diphtheriae chromosome was done
to identify restriction fragments that might carry the 5' regions of
these two genes. 32P-labeled DNA fragments obtained from
either plasmid pTSB2 or pTSB5 were used as probes to hybridize to a
chromosomal digest of C. diphtheriae C7(
) DNA (21,
34). Hybridization studies using the pTSB2 probe identified a
1.5-kb HindIII fragment that was predicted to contain
the 5' region of the sensor kinase gene chrS. Similarly,
hybridization analysis with a pTSB5 probe indicated that a 1.8-kb
EcoRV fragment present in the C. diphtheriae
chromosome contains the 5' portion of the cstS gene. Both
the 1.5-kb HindIII fragment and the 1.8-kb
EcoRV fragment contain approximately 500-bp sequences that
are present on the cloned sequences of pTSB2 and pTSB5, respectively.
The 1.5-kb HindIII fragment and the 1.8-kb EcoRV fragment were cloned into the pBluescript KS vector as
follows. C. diphtheriae chromosomal DNAs were digested
separately with either HindIII or EcoRV, and
DNA fragments in the size range of 1 to 3 kb were excised from a 1%
agarose gel, purified, and ligated into the appropriate restriction
sites in the KS vector. The recombinants were transformed into DH5
,
and then clones that carried the insert of interest were identified by
colony hybridization (34). Plasmid pKSH51 carried the 1.5-kb
HindIII insert and plasmid pR5-38 carried the 1.8-kb
EcoRV insert.
DNA sequence analysis.
The DNA sequences for both strands of
a 2,021-bp region that includes the complete sequence of the
chrS and chrA genes were determined.
Double-stranded DNA templates were sequenced by the chain termination
method of Sanger et al. (35) by using a DNA sequencing kit
from Amersham. The complete DNA sequences for both strands of a
2,404-bp region containing the cstS and cstA
genes were also determined. Sequences were compiled and analyzed by using the Genetics Computer Group (GCG) program (Madison, Wis.). Amino
acid homologies were identified by using a BLAST search of the
SwissProt protein database. Amino acid alignments were done by the GAP
program (GCG), and putative transmembrane regions were identified by
the TMpred program (16).
LacZ assays.
Cultures (18 h) of E. coli and
C. diphtheriae were used to inoculate fresh medium at a
1:100 dilution which was then grown for 16 to 18 h at 37°C with
shaking. Supplements were added to the medium as indicated. LacZ
activities were determined for E. coli by the method of
Miller (27) and for C. diphtheriae as previously
described (39).
Mutant construction.
A point mutation was introduced into
the chrA gene by using inverse PCR and utilizing the useful
properties of the class II restriction enzyme BsaI (New
England BioLabs, Beverly, Mass.). The mutation results in replacement
of the Asp residue at position 50 (D50) in the wild-type gene product
(ChrA) with an Asn (N50) in the mutant gene product (ChrAD50N). The
mutagenesis procedure utilized two 33-bp oligonucleotide primers,
MUTN50T,
5'-CGCGGTCTCACCAACATCCAAATGCCAGGCACC-3' (sense strand), and MUTN50B,
5'-CGCGGTCTCGTTGGTGACAACAACGTCGATGCC-3' (antisense strand), which each contain a unique BsaI
recognition site (underlined) and a single base change from the
wild-type chrA sequence (boldface type; G to A
for MUTN50T and C to T for MUTN50B). The 24 nt sequences at
the 3' ends of the two primers are complementary to sequences on
opposite strands of the chrA gene, while the 9 nt at the 5'
end contain noncomplementary sequences and include a BsaI
site. The primers are designed to anneal to circular template DNA
containing the cloned chrA gene in a tail-to-tail inverted
manner, such that there exists a 6-bp complementary overlap between the
primers in the region that is immediately 3' to the BsaI
site. The template DNA used for the PCR was the plasmid pKBH1.2, which
contains the 1.2-kb BglII-HindIII fragment
from pTSB2 (chrA+) ligated into the
BamHI-HindIII sites of pBluescript KS.
Inverse PCR was done by using Vent polymerase (New England BioLabs),
and the reaction mixture contained 10 ng of template DNA, 0.5 µg of each primer, and 300 µM deoxynucleoside triphosphates in 1× Vent polymerase buffer (New England BioLabs). The reaction was run under the
following conditions: 94°C for 30 s, 55°C for 30 s, and
72°C for 6 min for 28 cycles and a final cycle of 72°C for 10 min.
The 4-kb linear PCR product was digested with BsaI, which generated two large fragments, each of approximately 2 kb
(BsaI cuts within the ampicillin resistance gene on the
vector and also in the 5' tail regions of the primers). The two
fragments were ligated, and Ampr transformants were
isolated. Since BsaI has a cut site that is adjacent to, but
does not overlap, its recognition sequence, digestion of the PCR
product with BsaI followed by ligation will result in the
removal of the BsaI recognition sequence from the 5' tail regions of the primers without affecting any of the sequences 3' of the
recognition site and will generate complementary overhangs. Therefore,
BsaI digestion of the PCR product followed by ligation of
the two fragments is predicted to reconstitute the sequence of the
original plasmid, pKBH1.2, with the incorporation of a single
nucleotide substitution. Plasmid DNA was obtained from one of the
transformants, and the DNA sequence of the 1.2-kb insert was
determined, confirming the presence of the point mutation within the
chrA gene and further showing that no other sequence changes
had occurred. The resulting plasmid was designated pKBH1.2-D50N.
The plasmids pWBH20 and pWBH20-D50N were constructed by using a
two-step process that was similar to that used for the construction of
pTSB20. In the first step, the inserts in plasmids pKBH1.2 and
pKBH1.2-D50N were excised with PvuII and ligated into the EcoRV site of the low-copy-number vector pWKS30 to produce
pWBH1.5 and pWBH1.5-D50N, respectively. In the second step, 1.5-kb
HindIII fragments from pKSH51 were ligated into the
HindIII sites of pWBH1.5 and pWBH1.5-D50N to generate
plasmids pWBH20 and pWBH20-D50N, respectively. The Ptrc99A
expression vector was used to construct plasmids pPBH2 and pPBH2-D50N,
which contain the 1.2-kb inserts from pKBH1.2 and pKBH1.2-D50N, respectively.
Nucleotide sequence accession numbers.
The sequences of the
2,021-bp region containing chrS and chrA and the
2,404-bp region containing cstS and cstA were
assigned GenBank accession no. AF161327 and AF161328, respectively.
 |
RESULTS |
Sequences required for heme activation of the hmuO
promoter.
To identify sequences needed for the heme-dependent
activation of the hmuO promoter, six hmuO
promoter-lacZ transcriptional fusion constructs
(PhmuO-lac) that contained various amounts of C. diphtheriae DNA sequences upstream of the hmuO promoter
were created. Plasmid pCPO-1 contained 200 bp of upstream sequences, while plasmids pCPO-2 through pCPO-6 contained decreasing amounts of
the native C. diphtheriae sequences upstream of the
hmuO promoter (Fig. 1). The
six PhmuO-lac fusion plasmids were examined for transcriptional activity in C. diphtheriae C7(
) that was
grown in low-iron medium in the presence of heme. Expression of the PhmuO-lac fusion on plasmids pCPO-1, pCPO-2, and pCPO-3
resulted in similar levels of LacZ activity (Fig. 1). However, the
PhmuO-lac fusion on plasmid pCPO-4, which contained only 20 bp of upstream sequence, exhibited a twofold decrease in expression
relative to the fully induced levels seen with pCPO-1 (Fig. 1). The
plasmids pCPO-5 and pCPO-6 exhibited little if any heme-dependent
activation. C7(
) carrying pCPO-1 gave 2.3 U of LacZ activity in
low-iron medium in the absence of heme, and similar LacZ levels in the same medium were observed for DH5
carrying pCPO-2 through pCPO-6 (data not shown). Hemoglobin also activated the expression of the
hmuO promoter in a manner similar to that seen in the
presence of heme (data not shown). These findings indicate that
sequences upstream of the hmuO promoter are required for
heme induction and further suggest that the upstream region may contain
a binding site for a factor involved in the heme-responsive activation.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 1.
Linear maps of the hmuO promoter region
present on the six promoter-lac fusions. The hmuO
promoter is indicated by the 10 and 35 elements. The top line
indicates the distance from the 35 sequence in base pairs. The arrow
indicates the start site of transcription of the hmuO gene
(transcription begins at an A residue 40 bp downstream from the 5' end
of the 35 sequence [37]). LacZ activity (LacZ U) for
each fusion was determined in C. diphtheriae C7( ) grown in
low-iron medium in the presence of 25 µg of hemin/ml. LacZ units were
determined as previously described (39). Values are means of
three independent experiments, and standard deviations did not vary by
greater than 15% from the mean.
|
|
Identification of genes involved in the activation of the
hmuO promoter.
In an earlier study, it was shown that
the hmuO promoter is poorly expressed in E. coli
DH5
(37). Consistent with this earlier finding, the
PhmuO-lac fusion on pCPO-1 is also expressed at low levels
in DH5
(Table 1), and colonies of DH5
carrying pCPO-1 plated onto
LB agar medium containing X-Gal
(5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside) were
white, which is indicative of low-level LacZ expression (data not
shown). To identify the gene(s) that activates the expression of the
hmuO promoter, a C. diphtheriae chromosomal
library, which was constructed by using the expression plasmid
pTrc99A, was transformed into DH5
carrying the plasmid
pCPO-1. Transformants were plated onto LB agar medium containing X-Gal
and IPTG (IPTG was used to induce the trc promoter on
pTrc99A). Since DH5
carrying pCPO-1 produces white
colonies on LB medium containing X-Gal and IPTG, blue colonies should
represent transformants that contain recombinant clones capable of
activating the expression of the hmuO promoter present on
pCPO-1. Four blue colonies were identified after screening of
approximately 10,000 library transformants. The four unique clones were
designated pTSB1, pTSB2, pTSB3, and pTSB5 and had inserts of different
sizes that ranged from 2.8 kb for pTSB2 to 5.6 kb for pTSB1.
Restriction mapping analysis of these clones indicated that the entire
2.8-kb insert of the plasmid pTSB2 was contained within the larger
inserts of the plasmids pTSB1 and pTSB3 (Fig.
2A and data not shown). Additionally, the
inserts in pTSB1, pTSB2, and pTSB3 all shared the same left end
terminus relative to the map of pTSB2 shown in Fig. 2A. Restriction
analysis of the 3.7-kb insert in the plasmid pTSB5 indicated that it
did not share sequences with the other three plasmids (Fig.
3A). DH5
carrying pCPO-1 and carrying
each of the four putative activator clones produced blue colonies on
X-Gal-containing medium only in the presence of IPTG (data not shown).
This indicated that expression from the IPTG-inducible trc
promoter, present on pTrc99A, was essential for each of
these clones to activate the hmuO promoter. The dependence
on the trc promoter indicated that either the putative activator gene(s) on the four clones lacked their native C. diphtheriae promoter or the native promoter was inadequately
active in DH5
.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 2.
(A) Restriction maps of plasmid pTSB2 and various
subclones. The direction of transcription from the plasmid-encoded
trc promoter is indicated by the arrow. LacZ assays were
done with E. coli DH5 /pCPO-1 that carried the various
activator clones. Bacteria were grown in LB medium in the presence of
0.5 mM IPTG, and LacZ units were determined by the method of Miller
(27). Values are means of three independent experiments, and
standard deviations did not vary by greater than 15% from the mean.
(B) Genetic map of the chrS and chrA genes
present on plasmid pTSB2. The genetic map is aligned with the
restriction maps shown in panel A. (C) Restriction and genetic maps of
plasmid pTSB20. The thin boxed region below the restriction map
indicates the location of the 1.5-kb HindIII fragment
that is present in plasmid pKSH51 and contains the 5' portion of the
chrS gene. Only a portion of the HindIII
fragment is shown. The restriction and genetic maps are aligned with
each other and with the maps shown in panels A and B. Restriction sites
are as follows: B, BamHI; Bg, BglII; H,
HindIII; K, KpnI; Pv, PvuII. Sites
shown in parentheses indicate restriction sites present in vector
sequences.
|
|

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 3.
(A) Restriction maps of plasmid pTSB5 and various
subclones. Direction of transcription from the plasmid encoded
trc promoter is indicated by arrow. LacZ assays were done
with E. coli DH5 /pCPO-1 that carried the various
activator clones. Bacteria were grown in LB medium in the presence of
0.5 mM IPTG, and LacZ units (U) were determined by the method of Miller
(27). Values are means of three independent experiments, and
standard deviations did not vary by greater than 15% from the mean.
(B) Genetic map of the cstS and cstA genes
present on plasmid pTSB5. The genetic map is aligned with the
restriction maps shown in panel A. (C) Restriction and genetic maps of
plasmid pTSB50. The thin boxed region below the restriction map
indicates the location of the 1.8-kb EcoRV fragment that is
present in plasmid pR5-38 and contains the cstS gene. The
restriction and genetic maps are aligned with each other and to the
maps shown in panels A and B. Restriction sites are as follows: B,
BamHI; E, EcoRI; N, NruI; P,
PstI; S, SalI; V, EcoRV. Sites shown
in parentheses indicate restriction sites present in vector
sequences.
|
|
Effect of the activator clones on expression of the
hmuO promoter.
Expression of the hmuO
promoter on pCPO-1, pCPO-4, and pCPO-5, in the presence of the various
activator clones, was quantitated in liquid culture medium by measuring
-galactosidase levels (27). Only low levels of promoter
activity were seen with the four clones in the absence of IPTG (Table
1 and data not shown). Greater than
10-fold induction of LacZ activity was seen when DH5
carried both
pCPO-1 and either pTSB2 or pTSB5 and was grown in the presence of IPTG.
Similar LacZ levels were seen with the clones pTSB1 (13.2 U) and pTSB3
(9.6 U) in the presence of IPTG. The plasmids pTSB1 and pTSB3 were not
characterized further since these results suggested that all of the
sequences needed for activation of the hmuO promoter reside
in pTSB2. The PhmuO-lac fusion on pCPO-4 was less responsive than that on pCPO-1 to IPTG induction in the presence of plasmids pTSB2
and pTSB5; the LacZ levels were two- to threefold lower than those
observed with pCPO-1 (Table 1). The plasmids pTSB2 and pTSB5 did not
induce the expression of the PhmuO-lac fusion on pCPO-5.
These results showed that there exists a similar trend for the heme
activation obtained with pCPO-1, pCPO-4, and pCPO-5 in C. diphtheriae (Fig. 1) and for the induction caused by pTSB2 and
pTSB5 in E. coli.
Subclones of the plasmids pTSB2 and pTSB5 were constructed in
pTrc99A to identify the smallest region that would maintain induction of the hmuO promoter on pCPO-1. The smallest such
subclone from pTSB2 identified was pTSB2.K-Bg, which contained a 900-bp KpnI-BglII fragment (Fig. 2A). Subclones of pTSB2
which contained deletions at the left end had a five- to sixfold
increase in LacZ expression of the PhmuO-lac fusion on
pCPO-1 (Fig. 2A, plasmids pTSB2.H-Bg and pTSB2.K-Bg). The reason for
this increase in activation is not clear, although it may be due either
to the loss of a repressor function or to the more proximal location of
the putative activator gene to the trc promoter present on
the vector. The smallest subclone of pTSB5 maintaining induction was an
approximately 1-kb NruI fragment on pTSB5.N (Fig. 3A). No
significant differences in the activation of the hmuO
promoter were observed for any of the pTSB5 subclones.
To assess the effect that both activator genes together would have on
the expression of the hmuO promoter in E. coli,
DNA fragments from pTSB2 and pTSB5 were placed in tandem onto the pTrc99A vector to generate plasmid pTSB2-5. The presence of
pTSB2-5 in DH5
carrying pCPO-1 resulted in a high level of induction (352.1 U) of the hmuO promoter in the presence of IPTG
(Table 1). This level of expression was 25-fold higher than the LacZ activity seen with either of the activators alone: 11.4 U for pTSB2 and
13.7 U for pTSB5. This finding suggested that the presence of both
activators on the same plasmid caused a synergistic effect on the
activation of the hmuO promoter. Relatively high levels of
LacZ activity (55.7 U) were also detected with pTSB2-5 even in the
absence of IPTG induction (Table 1), which may have been caused by
low-level expression from the "leaky" trc promoter.
Almost all laboratory strains of E. coli, including DH5
,
are unable to transport heme through their outer membranes unless a
heme transport system, such as those present in certain bacterial pathogens, is provided in trans. The activation of the
hmuO promoter in DH5
carrying pCPO-1 and either pTSB2,
pTSB5, or pTSB2-5 was not affected by the addition of heme to the
medium even in the presence of the plasmid pSHU9 (28), which
encodes the S. dysenteriae heme transport system and enables
DH5
to transport heme (Table 1).
Sequence analysis of the activator genes on pTSB2 and pTSB5.
To identify the genes present on pTSB2 and pTSB5 that are required for
activation of the hmuO promoter, the DNA sequences of the
1.7-kb BamHI-BglII insert on pTSB2.Bg and the
1.2-kb left end region of plasmid pTSB5.R (Fig. 2A and Fig. 3A,
respectively) were determined. DNA sequence analysis indicated that a
single open reading frame was present in the
KpnI-BglII fragment from pTSB2.Bg (the smallest
subcloned region that maintains activation). This open reading frame
was designated chrA (Corynebacterium
heme-responsive activator) (Fig. 2B) and is predicted to encode a
product of 199 amino acids that has significant homology to response
regulators of two-component signal transduction systems. Immediately
upstream from chrA is a partial open reading frame for a
gene that is designated chrS (Corynebacterium
heme-responsive sensor), whose product has homology to the sensor
kinase component of two-component signal transduction systems (Fig.
2B). The chrS open reading frame is predicted to encode a
product containing 340 amino acids; however, the 5' portion of the
chrS coding region is not present on pTSB2 or the other two
related clones, pTSB1 and pTSB3. The chrS termination codon
TGA overlaps the ATG start codon for chrA, suggesting that the genes are organized as an operon similar to other genes encoding two-component systems. Since chrA is the only complete gene
present on the KpnI-BglII fragment on plasmid
pTSB2.K-Bg, this suggests that only the response regulator is needed
for activation of the hmuO promoter in E. coli
and this effect is observed only when the IPTG-inducible trc
promoter is active.
Sequence analysis of the 1.2-kb region of pTSB5.R revealed that a
single open reading frame was present on the 1-kb NruI
fragment, and this open reading frame, designated cstA for
Corynebacterium signal transduction activator, also has
significant homology to response regulators of two-component systems
(Fig. 3B). Upstream from cstA is a partial open reading
frame for a gene designated cstS, which is predicted to
encode the C-terminal 137 amino acids of a sensor kinase. The predicted
amino acid sequences of CstA and ChrA show the highest homology to
proteins in the NarL and NarP family of response regulators (both ChrA
and CstA show homologies to proteins in this family that range from 30 to 40% amino acid identity over the entire length of the protein).
Proteins in this family of response regulators are known to bind DNA
and function as transcriptional activators (32). ChrA and
CstA are greater than 40% identical to each other at the amino acid
level and share numerous residues that are conserved among all response
regulators within the NarL and NarP family (Fig.
4) (1). The conserved amino
acids include an aspartate residue (Asp50 for ChrA and Asp54 for CstA),
which is the site of phosphorylation in other response regulators
(32).

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 4.
Amino acid sequence alignment of ChrA and CstA. Amino
acid residues that are highly conserved among other response regulators
within the NarP and NarL family (1) are shown in boldface.
The conserved Asp (D) residues marked with an asterisk (D50 in ChrA and
D54 in CstA) are known to be the sites of phosphorylation in other
response regulators.
|
|
Cloning and sequence analysis of the sensor kinase homologs encoded
by chrS and cstS.
Although the chrA
and cstA genes were able to activate the expression of the
hmuO promoter in E. coli, the heme-dependent activation of hmuO observed in C. diphtheriae
could not be reconstituted in E. coli with either of these
genes. To determine if the sensor kinase genes, chrS and
cstS, are needed for heme-dependent activation in E. coli, the 5' portions of these genes along with upstream regions
were cloned from the chromosome of C. diphtheriae. A 1.5-kb HindIII fragment, which carries the 5' region of the
chrS gene, was used to construct the plasmid pTSB20, which
contains the complete coding region for chrS and
chrA (Fig. 2C). Similarly, a 1.8-kb EcoRV
fragment that was cloned from the chromosome of C. diphtheriae was used to construct the plasmid pTSB50, which
contains the complete coding region for cstS and
cstA (Fig. 3C). The plasmids pTSB20 and pTSB50 contain the
pSC101 origin of replication and replicate at a low copy number in
E. coli. Low-copy-number plasmids were used in the analysis
of the chrS and cstS genes since the predicted products of these genes are presumed to be membrane associated and
could be deleterious at high levels.
Sequence analysis of the chrS and cstS genes
indicated that they are predicted to encode proteins of 417 and 408 amino acids, respectively. Both proteins showed the highest homology
(approximately 30% identity) in their C-terminal halves to the UhpB
and DegS sensor kinases (data not shown). The putative sensor domain of CstS, located at the N-terminal region, had no significant homology with any proteins in the GenBank database. The N-terminal sensor domain
of ChrS had 28% identity with the N-terminal region of the SenR
protein from Streptomyces reticuli (GenBank accession no.
Y14336). The ChrS and SenR proteins are 36% identical at the amino
acid level over their entire sequences. A specific function for SenR
has not been reported, although it is proposed to function as the
sensor component in a two-component system. Analysis of the amino acid
sequences for both ChrS and CstS, using the TMpred program, predicts
both proteins to have multiple transmembrane helices in their
N-terminal 200 amino acids (data not shown).
Effect of chr and cst operons on the
expression of the hmuO promoter.
Plasmid pTSB20
(chrS+, chrA+) and
plasmid pTSB50 (cstS+,
cstA+) were transformed into DH5
carrying
pCPO-1 to determine what effect these genes had on the expression of
the PhmuO-lac fusions in the presence and absence of heme.
Plasmid pTSB20 in DH5
carrying pCPO-1 showed relatively low LacZ
activity regardless of the presence heme (Table
2). However, when pSHU9, which carries a
heme transport system, was moved into this strain, greater than 20-fold
induction was seen in the presence of heme (the LacZ activity was 4.6 U in the absence of heme and 102.5 U in the presence of heme [Table 2]). This high level of heme induction was dependent on the presence of a functional heme transport system supplied by the pSHU9 plasmid. Heme activation in E. coli also required the presence of
both the chrS and chrA genes, since clones
(constructed on the same low-copy-number plasmids) containing only the
chrA gene did not exhibit heme induction (data not shown).
Furthermore, the presence of pTSB20 also conferred heme induction on
the PhmuO-lac fusion on pCPO-4, but only very low LacZ
activity was seen with pCPO-5 (Table 2). The relative levels of
heme-induced expression from the PhmuO-lac fusions on
pCPO-1, pCPO-4, and pCPO-5 by pTSB20 (chrA+,
chrS+) in E. coli are similar to
those observed for the same PhmuO-lac fusions in C. diphtheriae (Fig. 1). The plasmid pTSB50 transformed into DH5
carrying pCPO-1 and pSHU9 showed only a low level of LacZ activity that
was not affected by the presence of heme (Table 2). Plasmid pTSB20-50,
which contained the inserts of both pTSB20 and pTSB50 on the same
low-copy-number plasmid, showed a level of heme-induced LacZ activity
in DH5
carrying pCPO-1 and pSHU9 (96 U) that was similar to that
observed for pTSB20.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Effects of sensor and/or activator clones on the
expression of PhmuO-lac fusions in the presence and
absence of heme in DH5
|
|
Effect of the chrAD50N mutant allele on expression of
the hmuO promoter.
Site-directed mutagenesis was used
to introduce a point mutation into the chrA gene which
resulted in the replacement of the aspartate residue at position 50 with an asparagine. Based on sequence homologies with other response
regulators, the Asp50 residue in ChrA is the presumed site of
phosphorylation by its cognate sensor kinase ChrS. The plasmid
pWBH20-D50N, which carries both the mutant chrA allele
(chrAD50N) and the wild-type chrS gene on the
low-copy-number vector pWKS30, was examined to determine the effect of
the chrAD50N mutation on the heme-dependent activation of
the hmuO promoter. DH5
carrying both pCPO-1 and
pWBH20-D50N showed only low LacZ activity and very weak heme-dependent
activation of the PhmuO-lac fusion present on pCPO-1 (Table
3). Plasmid pWBH20, which carries the
wild-type copies of the chrA and chrS genes on
pWKS30, showed levels of heme-dependent activation of the
PhmuO-lac fusion that were greater than 18-fold higher than those observed for the chrAD50N mutant allele (the LacZ
activities were 66.4 and 3.6 U, respectively [Table 3]). These
results indicated that replacement of the Asp residue at position 50 with an Asn in the chrAD50N gene product virtually abolished
all heme-responsive activation when chrAD50N was expressed
from a low-copy-number plasmid.
However, when the chrAD50N allele was present on the
higher-copy-number vector pTrc99A (pPBH2-D50N) and expressed
from the strong IPTG-inducible trc promoter, the
chrAD50N gene product exhibited a capacity to activate the
hmuO promoter that was only twofold lower than the
activation observed for the wild-type chrA gene on plasmid
pPBH2 (the activities were 32.4 and 61.8 U, respectively [Table 3]).
Activation of the PhmuO-lac fusion by both the wild-type chrA gene and the chrAD50N allele required the
presence of IPTG, and this activation occurred in the absence of the
chrS gene, since chrS is not present on the
plasmid pPBH2-D50N or pPBH2. This finding indicates that the
chrAD50N gene product has the capability to activate
transcription, although at reduced levels relative to those induced by
the wild-type gene product, and that the Asp50 residue is not essential
for transcriptional activation if the gene is expressed at high levels.
 |
DISCUSSION |
Bacteria utilize a variety of mechanisms to adapt to and interact
with the environment, including the well-characterized two-component signal transduction systems (for a review see reference
32). Two-component regulatory systems typically
consist of a sensor protein that monitors the environment and a cognate
response regulator which is involved in controlling gene expression. In
this study, the mechanism involved in the heme-responsive activation of
the hmuO promoter has been reconstituted in E. coli. The genes, chrS and chrA, that encode
homologs of two-component signal transduction systems were shown to
activate the expression of a PhmuO-lac fusion construct in
E. coli. The activation required heme or hemoglobin in the
growth medium and a functional heme transport system that was provided
in trans. Although this system has been reconstituted in an
E. coli background, it very closely mimics the
heme-dependent activation observed in C. diphtheriae, which
strongly suggests that chrS and chrA are the
relevant activators in C. diphtheriae.
The hmuO gene is the only bacterial gene whose expression is
known to be activated by heme, and this is the first report in which
heme has been identified as the environmental stimulus for a
two-component regulatory system. Relatively little is known about
heme-regulated gene expression in other bacterial systems. Numerous
bacterial pathogens can transport and utilize heme as an iron source,
and most of the genes that encode products mediating these heme
transport functions are regulated by iron (22, 30, 51).
However, the expression of certain proteins involved in the transport
of heme and iron by pathogenic species of Haemophilus (8, 19, 29) and Porphyromonas (9, 20)
has been shown to be heme repressible. The mechanisms involved in the
regulation of genes encoding heme-repressed proteins in these organisms
have not been described.
Sequences upstream from the hmuO promoter were shown to be
important for heme-dependent transcription both in C. diphtheriae and in E. coli. The PhmuO-lac
fusion on plasmid pCPO-3, which contained only 50 bp of C. diphtheriae-specific sequences upstream of the
35 sequence
(which is 90 bp upstream from the start of transcription
[37]), was fully induced by heme. The
PhmuO-lac fusions on pCPO-4 and pCPO-5, which had fewer
upstream sequences than pCPO-3, showed significantly reduced heme
induction. These findings indicate that sequences within the 90-bp
region upstream from the start site of transcription from the
hmuO promoter, and most likely upstream of the
35 element,
are required for heme induction and may contain the binding site for
the response regulator encoded by the chrA gene. In support
of this possibility, the related response regulators, NarP, NarL, and
UhpA, bind to sequences within 80 bp of the transcriptional start sites
of some of the genes that they regulate (6, 7).
The activator clones pTSB2 and pTSB5, which contain the chrA
and cstA genes, respectively, were isolated from a plasmid
library due to their ability to activate the expression of the
PhmuO-lac fusion on pCPO-1 in E. coli. The cloned
chrA and cstA genes in E. coli are
able to activate the transcription of the hmuO promoter in
the absence of their cognate sensor kinase genes, chrS and cstS, respectively. Several factors may contribute to the
capacity of the chrA and cstA genes to activate
transcription in the absence of their cognate sensor kinases. These
include (i) low-level phosphorylation of ChrA and CstA by endogenous
nonspecific kinases in E. coli, (ii) cross talk with other
two-component systems, and (iii) overexpression of the products of the
chrA and cstA genes due to the presence of these
genes on high-copy-number plasmids. The expression of these genes is
further enhanced since they are under the transcriptional control of
the IPTG-induced trc promoter. Other investigators have made
observations similar to those described here showing that multicopy
plasmids carrying genes encoding response regulators are able to
activate transcription in the absence of their cognate sensor kinases
(11, 48).
The deletion constructs pTSB2.H-Bg and pTSB2.K-Bg, which carry the
chrA gene and a portion of the 3' region of chrS,
exhibited an enhanced activity relative to the activity of the parent
clone, pTSB2 (Fig. 2A). This enhanced activity may be due to the more proximal location of the chrA gene to the trc
promoter or to the deletion of sequences containing the chrS
gene. The truncated chrS gene present on either pTSB2.H-Bg
or pTSB2.K-Bg lacks the codon for the conserved histidine (H215), which
is proposed to be the site of phosphorylation and is predicted to be
essential for the activities of sensor kinases. The truncated
chrS gene on the parent clone pTSB2 contains this conserved
histidine (H215)-encoding codon, and it is possible that any putative
peptide produced from this truncated chrS gene (either
initiating from a weak internal start codon or present as part of a
translational fusion with upstream vector sequences) could potentially
have activity. Since sensor kinases are known to have both positive and
negative effects on the activities of their cognate response regulators
(32), it is possible that a truncated ChrS product produced
from pTSB2 may exert a repressor effect on the ChrA activator. However,
when the conserved histidine codon is removed from the chrS
sequence, as in the two-deletion constructs, the repressor effect is
alleviated and enhanced expression is observed.
The chrAD50N mutant allele, when expressed at high levels,
was also able to activate transcription of the hmuO promoter
in the absence of its cognate sensor kinase. Similarly, other
investigators have shown that a mutation in the gene encoding the
E. coli UhpA response regulator, in which the Asp54 residue
(the site of phosphorylation by its cognate sensor kinase) is replaced
with an Asn, results in the loss of all activity when the gene is
present in low copy number but that transcriptional activity is
maintained when the gene is expressed from a multicopy plasmid
(48). The presumed DNA binding domain for ChrA, based on
sequence homologies with other response regulators in the NarP and NarL
family, is predicted to be located in the C-terminal portion of the
protein and would not be directly affected by the D50N mutation. The
results obtained with the ChrAD50N and UhpAD54N response regulators
indicate that phosphorylation at the conserved Asp residue is not
essential for activating transcription when these proteins are strongly expressed.
The findings in this study indicate that the two genes chrA
and cstA are able to activate expression at the
hmuO promoter. Additionally, both genes showed similar
levels of activation when expressed in the various promoter deletion
constructs (Table 1), which suggests that the products of
chrA and cstA may have DNA binding sites that are
very near each other. Plasmid pTSB2-5, which carries both the
chrA and cstA genes under control of the trc promoter, activates transcription of the
PhmuO-lac fusion on pCPO-1 to levels greater than 25-fold
higher than those produced by either pTSB2 or pTSB5, each of which
carries only one of the activators (Table 1). Evaluation of the results
for the tandem construct is difficult since protein levels are not
known. While it is clear that additional studies are required to fully
understand the mechanism of this enhanced activity of the
chrA and cstA genes on pTSB2-5, one possible
mechanism by which the expression may be increased could involve the
formation of mixed dimers or multimers of the ChrA and CstA proteins.
Since the DNA binding sites of ChrA and CstA may be close to each
other, the presence of mixed multimers may result in either greater
stability of a protein-DNA complex or an alteration of the conformation
of the proteins so that there exists a more optimal interaction with
RNA polymerase, which results in the enhanced transcription.
The presence of both response regulators, chrA and
cstA, and their cognate sensors, chrS and
cstS, together on plasmid pTSB20-50 did not result in a
synergistic effect similar to that seen for pTSB2-5, which contained
only the response regulator genes. Since the presence of
cstA and cstS on the same plasmid, pTSB50, failed to activate the expression of the hmuO promoter, it is
unclear what role, if any, the cstA and cstS
genes have in the regulation of the hmuO promoter in
C. diphtheriae. Since cstA did not activate the
hmuO promoter in the presence of the cstS gene
but did in the absence of cstS, it is possible that the
product of cstS may repress the activity of cstA.
It is possible that an environmental factor other than heme may be
required for the cstA-cstS system to activate transcription
at the hmuO promoter. Additional studies are needed to
define the role of the cstA and cstS genes in
C. diphtheriae.
It is clear from the results of this study that heme-dependent
activation of the hmuO promoter in E. coli
requires the presence of both the chrA and chrS
genes and a functional heme transport system, which serves to transport
heme through the outer membrane. The evidence strongly suggests that
the putative sensor kinase encoded by chrS is involved in
the detection of heme, which is presumed to be the environmental
signal. Alternatively, it is possible that the actual environmental
stimulus is not heme but is a factor that is produced in response to
the presence of heme in the medium. While additional studies are
required to determine the mechanism by which ChrS detects heme (or
other signals), it is likely that sequences in the N-terminal portion
or sensor domain of ChrS are involved in the detection of the
environmental stimulus. Amino acid sequence analysis using the TMpred
program predicts that there are at least four transmembrane helices in
the N-terminal 180 amino acids of ChrS. Extracytoplasmic loop regions
between transmembrane helices have been proposed to be involved in the detection of environmental stimuli by other sensor kinases (4, 32), and it is plausible that regions between the putative
membrane-spanning regions in ChrS may have a role in the detection of
heme. In the reconstituted system in E. coli, it is proposed
that the ChrS protein resides in the cytoplasmic membrane and that the
extracytoplasmic loop regions are involved in the detection of heme
that has been transported into the periplasm by means of the heme
transport system encoded by the genes present on the plasmid pSHU9. In
the gram-positive organism C. diphtheriae, ChrS is also
predicted to reside in the cytoplasmic membrane; however, the
extracytoplasmic loop regions would be involved in detecting
extracellular heme. If the activity of ChrS is like that of other
related sensor kinases, it is presumed that detection of an
environmental stimulus by ChrS should result in autophosphorylation at
the conserved histidine residue, H215. The phosphoryl group on H215
could then be transferred to the conserved Asp residue (D50) on ChrA,
which would allow ChrA to activate transcription at the hmuO
promoter. The findings from this study indicate that the D50 residue in
ChrA is needed for heme-responsive activation of the hmuO
promoter, since the ChrAD50N protein had little if any capacity to
activate the hmuO promoter in the presence of heme (Table
3). This observation supports the sequence homology data which predicts
that the D50 residue of ChrA functions as the site of phosphorylation
by ChrS and, therefore, should have a direct role in a heme-dependent signal transduction mechanism. A model depicting how this
phosphotransfer signaling mechanism may function to control
hmuO transcription in C. diphtheriae is presented
in Fig. 5.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 5.
Proposed mechanism of heme-responsive activation at the
hmuO promoter in C. diphtheriae. The sensor
kinase ChrS is proposed to detect extracellular heme at its N-terminal
sensor domain, which is predicted to contain at least two transmembrane
helices (indicated by striped ovals) and two extracellular loop
regions. The detection of heme by ChrS is proposed to result in
autophosphorylation at a conserved histidine (H, H215) that is located
in the cytosolic kinase domain of ChrS (boxed region). The phosphoryl
group (indicated by a circled P) is then transferred to a conserved Asp
residue (D, D50) on ChrA. Phosphorylation is proposed to activate the
DNA binding ability of ChrA and allows ChrA to bind upstream of the
hmuO promoter and activate transcription. Transcription of
the hmuO promoter can also be repressed by DtxR during
growth in the presence of iron. The hmuO gene, therefore, is
optimally expressed in low-iron environments in the presence of heme.
Additionally, a C. diphtheriae heme-specific transporter has
been proposed to be involved in the transport of heme into the cytosol
(7a), where the HmuO protein is proposed to degrade the
cytosolic heme and liberate the heme-bound iron.
|
|
While the construction of defined mutations in the chrS
and/or chrA genes in the chromosome of C. diphtheriae should provide additional evidence for the function of
these genes in C. diphtheriae, the capability to perform
allelic replacement or transposon mutagenesis in C. diphtheriae is not yet available due to the lack of genetic tools.
The findings in this study expand our knowledge as to the variety of
environmental factors that can function as stimuli for two-component
systems. The regulatory systems reported in this study are the first
two-component signal transduction systems described for the genus
Corynebacterium, and future research will focus on
identifying additional genes controlled by these regulatory systems and
the characterization of functional domains present in these regulatory proteins.
 |
ACKNOWLEDGMENTS |
I thank Scott Stibitz for advice on the mutagenesis technique and
for his helpful comments on the manuscript. I also thank Clare Schmitt
and Sue Drazek for helpful comments and discussions.
 |
FOOTNOTES |
*
Mailing address: Division of Bacterial Products, CBER,
FDA, Building 29, Room 108, 8800 Rockville Pike, Bethesda, MD 20892. Phone: (301) 435-2424. Fax: (301) 402-2776. E-mail:
schmitt{at}cber.fda.gov.
 |
REFERENCES |
| 1.
|
Baikalov, I.,
I. Schroder,
M. Kaczor-Grzeskowiak,
K. Grzeskowiak,
R. P. Gunsalus, and R. E. Dickerson.
1996.
Structure of the E. coli response regulator NarL.
Biochemistry
35:11053-11061[Medline].
|
| 2.
|
Boyd, J. M.,
O. N. Manish, and J. R. Murphy.
1990.
Molecular cloning and DNA sequence analysis of a diphtheria tox iron-dependent regulatory element (dtxR) from Corynebacterium diphtheriae.
Proc. Natl. Acad. Sci. USA
87:5968-5972[Abstract/Free Full Text].
|
| 3.
|
Braun, V.,
K. Hantke, and W. Koster.
1998.
Bacterial iron transport: mechanisms, genetics, and regulation.
Met. Ions Biol. Syst.
35:67-145[Medline].
|
| 4.
|
Chiang, R. C.,
R. Cavicchiol, and R. P. Gunsalus.
1997.
"Locked-on" and "locked-off" signal transduction mutations in the periplasmic domain of the Escherichia coli NarQ and NarX sensors affect nitrate- and nitrite-dependent regulation by NarL and NarP.
Mol. Microbiol.
24:1049-1060[Medline].
|
| 5.
|
Cornejo, J.,
R. D. Willows, and S. I. Beale.
1998.
Phytobilin biosynthesis: cloning and expression of a gene encoding soluble ferredoxin-dependent heme oxygenase from Synechocystis sp. PCC 6803.
Plant J.
15:99-107[Medline].
|
| 6.
|
Dahl, J. L.,
B.-Y. Wei, and R. J. Kadner.
1997.
Protein phosphorylation affects binding of the Escherichia coli transcription activator UhpA to the uhpT promoter.
J. Biol. Chem.
272:1910-1919[Abstract/Free Full Text].
|
| 7.
|
Darwin, A. J.,
K. L. Tyson,
S. J. W. Busby, and V. Stewart.
1997.
Differential regulation by the homologous response regulators NarL and NarP of Escherichia coli K-12 depends on DNA binding site arrangement.
Mol. Microbiol.
25:583-595[Medline].
|
| 7a.
| Drazek, E. S., et al. Submitted for publication.
|
| 8.
|
Elkins, C.
1995.
Identification and purification of a conserved heme-regulated hemoglobin-binding outer membrane protein from Haemophilus ducreyi.
Infect. Immun.
63:1241-1245[Abstract].
|
| 9.
|
Genco, C. A.,
B. M. Odusanya, and G. Brown.
1994.
Binding and accumulation of hemin in Porphyromonas gingivalis are induced by hemin.
Infect. Immun.
62:2885-2892[Abstract/Free Full Text].
|
| 10.
|
Griffiths, E.
1991.
Iron and bacterial virulence a brief overview.
Biol. Met.
4:7-13[Medline].
|
| 11.
|
Haldimann, A.,
S. L. Fisher,
L. L. Daniels,
C. T. Walsh, and B. L. Wanner.
1997.
Transcriptional regulation of the Enterococcus faecium BM4147 vancomycin resistance gene cluster by the VanS-VanR two-component regulatory system in Escherichia coli K-12.
J. Bacteriol.
179:5903-5913[Abstract/Free Full Text].
|
| 12.
|
Hanahan, D.
1983.
Studies on transformation of Escherichia coli with plasmids.
J. Mol. Biol.
166:557-580[Medline].
|
| 13.
|
Hantke, K.
1984.
Cloning of the repressor protein gene of iron regulated systems in Escherichia coli K-12.
Mol. Gen. Genet.
197:337-341[Medline].
|
| 14.
|
Haynes, J. A., and M. L. Britz.
1989.
Electrotransformation of Brevibacterium lactofermentum and Corynebacterium glutamicum: growth in Tween 80 increases transformation frequencies.
FEMS Microbiol. Lett.
61:329-334.
|
| 15.
|
Henderson, D. P., and S. M. Payne.
1994.
Characterization of the Vibrio cholerae outer membrane heme transport protein HutA: sequence of the gene, regulation of expression, and homology to the family of TonB-dependent proteins.
J. Bacteriol.
176:3269-3277[Abstract/Free Full Text].
|
| 16.
|
Hofmann, D., and W. Stoffel.
1993.
Tmbase a database of membrane spanning protein segments.
Biol. Chem. Hoppe-Seyler
347:116.
|
| 17.
|
Holmes, R. K., and L. Barksdale.
1969.
Genetic analysis of tox+ and tox bacteriophages of Corynebacterium diphtheriae.
J. Virol.
3:586-598[Abstract/Free Full Text].
|
| 18.
|
Hornung, J. M.,
H. A. Jones, and R. D. Perry.
1996.
The hmu locus of Yersinia pestis is essential for utilization of free haemin and haem-protein complexes as iron sources.
Mol. Microbiol.
20:725-739[Medline].
|
| 19.
|
Jin, H.,
Z. Ren,
J. M. Pozsgay,
C. Elkins,
P. W. Whitby,
D. J. Morton, and T. L. Stull.
1996.
Cloning of a DNA fragment encoding a heme-repressible hemoglobin-binding outer membrane protein from Haemophilus influenzae.
Infect. Immun.
64:3134-3141[Abstract].
|
| 20.
|
Karunakaran, T.,
T. Maden, and H. Kuramitsu.
1997.
Isolation and characterization of a hemin-regulated gene, hemR, from Porphyromonas gingivalis.
J. Bacteriol.
179:1898-1908[Abstract/Free Full Text].
|
| 21.
|
Kidd, F. J.
1983.
In-situ hybridization to agarose gels.
Focus
6:3-4.
|
| 22.
|
Lee, C. B.
1995.
Quelling the red menace: heme capture by bacteria.
Mol. Microbiol.
18:383-390[Medline].
|
| 23.
|
Lee, J. H.,
T. Wang,
K. Ault,
J. Liu,
M. P. Schmitt, and R. K. Holmes.
1997.
Identification and characterization of three new promoter/operators from Corynebacterium diphtheriae that are regulated by the diphtheria toxin repressor (DtxR) and iron.
Infect. Immun.
65:4273-4280[Abstract].
|
| 24.
|
Litwin, C. M., and S. B. Calderwood.
1993.
Role of iron in regulation of virulence genes.
Clin. Microbiol. Rev.
6:137-149[Abstract/Free Full Text].
|
| 25.
|
Maines, M. D.
1992.
Characterization and regulation of heme oxygenase isozymes, p. 109-144.
In
M. D. Maines (ed.), Heme oxygenase: clinical applications and functions. CRC Press, Boca Raton, Fla.
|
| 26.
|
Mietzner, T. A., and S. A. Morse.
1994.
The role of iron-binding proteins in the survival of pathogenic bacteria.
Annu. Rev. Nutr.
14:471-493[Medline].
|
| 27.
|
Miller, J. H.
1972.
Experiments in molecular genetics.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 28.
|
Mills, M., and S. M. Payne.
1995.
Genetics and regulation of heme iron transport in Shigella dysenteriae and detection of an analogous system in Escherichia coli O157:H7.
J. Bacteriol.
177:3004-3009[Abstract/Free Full Text].
|
| 29.
|
Morton, D. J.,
J. M. Musser, and T. L. Stull.
1993.
Expression of the Haemophilus influenzae transferrin receptor is repressible by hemin but not elemental iron alone.
Infect. Immun.
61:4033-4037[Abstract/Free Full Text].
|
| 30.
|
Occhino, D. A.,
E. E. Wycoff,
D. P. Henderson,
T. J. Wrona, and S. M. Payne.
1998.
Vibrio cholerae iron transport: haem transport genes are linked to one of two sets of tonB, exbB, and exbD genes.
Mol. Microbiol.
29:1493-1507[Medline].
|
| 31.
|
Pappenheimer, A. M., Jr.
1977.
Diphtheria toxin.
Annu. Rev. Biochem.
46:69-94[Medline].
|
| 32.
|
Parkinson, J. S., and E. C. Kofoid.
1992.
Communication modules in bacterial signaling proteins.
Annu. Rev. Genet.
26:71-112[Medline].
|
| 33.
|
Rogers, H. J.
1973.
Iron-binding catechols and virulence in Escherichia coli.
Infect. Immun.
7:445-458[Abstract/Free Full Text].
|
| 34.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 35.
|
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467[Abstract/Free Full Text].
|
| 36.
|
Schmitt, M. P.
1997.
Utilization of host iron sources by Corynebacterium diphtheriae: identification of a gene whose product is homologous to eukaryotic heme oxygenaese and is required for acquisition of iron from heme and hemoglobin.
J. Bacteriol.
179:838-845[Abstract/Free Full Text].
|
| 37.
|
Schmitt, M. P.
1997.
Transcription of the Corynebacterium diphtheriae hmuO gene is regulated by iron and heme.
Infect. Immun.
65:4634-4641[Abstract].
|
| 38.
|
Schmitt, M. P., and R. K. Holmes.
1991.
Iron-dependent regulation of diphtheria toxin and siderophore expression by the cloned Corynebacterium diphtheriae repressor gene dtxR in C. diphtheriae C7 strains.
Infect. Immun.
59:1899-1904[Abstract/Free Full Text].
|
| 39.
|
Schmitt, M. P., and R. K. Holmes.
1991.
Characterization of a defective diphtheria toxin repressor (dtxR) allele and analysis of dtxR transcription in wild-type and mutant strains of Corynebacterium diphtheriae.
Infect. Immun.
59:3903-3908[Abstract/Free Full Text].
|
| 40.
|
Schmitt, M. P., and R. K. Holmes.
1994.
Cloning, sequence, and footprint analysis of two promoter/operators from Corynebacterium diphtheriae that are regulated by the diphtheria toxin repressor (DtxR) and iron.
J. Bacteriol.
176:1141-1149[Abstract/Free Full Text].
|
| 41.
|
Schmitt, M. P.,
B. G. Talley, and R. K. Holmes.
1997.
Characterization of lipoprotein IRP1 from Corynebacterium diphtheriae, which is regulated by the diphtheria toxin repressor (DtxR) and iron.
Infect. Immun.
65:5364-5367[Abstract].
|
| 42.
|
Shiller, J.,
B. Groman, and M. Coyle.
1980.
Plasmids in Corynebacterium diphtheriae and diphtheroids mediating erythromycin resistance.
Antimicrob. Agents Chemother.
18:814-821[Abstract/Free Full Text].
|
| 43.
|
Stojiljkovic, I., and K. Hantke.
1992.
Hemin uptake system of Yersinia enterocolitica: similarities with other TonB-dependent systems in gram negative bacteria.
EMBO J.
11:4359-4367[Medline].
|
| 44.
|
Stojiljkovic, I., and K. Hantke.
1994.
Transport of hemin across the cytoplasmic membrane through a hemin-specific periplasmic binding-protein-dependent transport system in Yersinia enterocolitica.
Mol. Microbiol.
13:719-732[Medline].
|
| 45.
|
Tao, X.,
S. Nikolaus,
H. Zeng,
D. Ringe, and J. R. Murphy.
1994.
Iron, DtxR and the regulation of diphtheria toxin expression.
Mol. Microbiol.
14:191-197[Medline].
|
| 46.
| |